Review



primary human dermal lymphatic endothelial cells lecs  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    PromoCell primary human dermal lymphatic endothelial cells lecs
    Primary Human Dermal Lymphatic Endothelial Cells Lecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+human+dermal+lymphatic+endothelial+cells+lecs/Human+Dermal+Lymphatic+Endothelial+Cells+(HDLEC)+juvenile+foreskin/bio_rxiv__64898__2026__01__30__702887-112-0-7
    Average 96 stars, based on 142 article reviews
    primary human dermal lymphatic endothelial cells lecs - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: Hydrogen sulfide donor activates AKT-eNOS signaling and promotes lymphatic vessel formation.
    Article Snippet: .. Primary human dermal lymphatic endothelial cells (LECs) isolated from adult skin were purchased from PromoCell GmbH (Heidelberg, Germany, Lot # 478Z013.2) and cultured in endothelial cell growth medium MV2 (PromoCell) supplemented with endothelial growth bullet kit along with 5% fetal bovine serum (FBS) and 1% penicillin (100 IU/mL)-streptomycin (100 ug/mL) solution. ..

    Article Title: Hydrogen sulfide donor activates AKT-eNOS signaling and promotes lymphatic vessel formation
    Article Snippet: .. Primary human dermal lymphatic endothelial cells (LECs) isolated from adult skin were purchased from PromoCell GmbH (Heidelberg, Germany, Lot # 478Z013.2) and cultured in endothelial cell growth medium MV2 (PromoCell) supplemented with endothelial growth bullet kit along with 5% fetal bovine serum (FBS) and 1% penicillin (100 IU/mL)-streptomycin (100 ug/mL) solution. ..

    Cell Culture:

    Article Title: Hydrogen sulfide donor activates AKT-eNOS signaling and promotes lymphatic vessel formation.
    Article Snippet: .. Primary human dermal lymphatic endothelial cells (LECs) isolated from adult skin were purchased from PromoCell GmbH (Heidelberg, Germany, Lot # 478Z013.2) and cultured in endothelial cell growth medium MV2 (PromoCell) supplemented with endothelial growth bullet kit along with 5% fetal bovine serum (FBS) and 1% penicillin (100 IU/mL)-streptomycin (100 ug/mL) solution. ..

    Article Title: Proximity interactome of lymphatic VE-cadherin reveals mechanisms of junctional remodeling and reelin secretion
    Article Snippet: HEK293T cells stably expressing either VE-cadherin-T or VE-cadherin-mT were generated using 100 μL unconcentrated virus + 10 μg/mL polybrene (EMD Milipore, #TR-1003-G) to enhance transduction efficiency and selected using 2 μg/mL puromycin. .. Primary human dermal lymphatic endothelial cells (LECs) (PromoCell, #C-12216) were cultured in Endothelial Cell Growth Medium (EGM-MV2) bullet kit medium (PromoCell, #C-22121) 37°C under 5% CO 2 . ..

    Article Title: Hydrogen sulfide donor activates AKT-eNOS signaling and promotes lymphatic vessel formation
    Article Snippet: .. Primary human dermal lymphatic endothelial cells (LECs) isolated from adult skin were purchased from PromoCell GmbH (Heidelberg, Germany, Lot # 478Z013.2) and cultured in endothelial cell growth medium MV2 (PromoCell) supplemented with endothelial growth bullet kit along with 5% fetal bovine serum (FBS) and 1% penicillin (100 IU/mL)-streptomycin (100 ug/mL) solution. ..

    Article Title: Proximity interactome of lymphatic VE-cadherin reveals mechanisms of junctional remodeling and reelin secretion.
    Article Snippet: Primary human dermal lymphatic endothelial cells (LECs) (PromoCell, #C-12216) were cultured in Endothelial Cell Growth Medium (EGM-MV2) bullet kit medium (PromoCell, #C-22121) 37°C under 5% CO2. .. Primary human dermal lymphatic endothelial cells (LECs) (PromoCell, #C-12216) were cultured in Endothelial Cell Growth Medium (EGM-MV2) bullet kit medium (PromoCell, #C-22121) 37°C under 5% CO2. .. The following ligands and inhibitorswereutilized throughout this study: human Adrenomedullin (Bachem, #4030215.1000), Rasarfin (MedChemExpress, #HY139950), Endosidin2 (Sigma-Aldrich, #SML1681), and (R)-MG132 (Sigma-Aldrich, #M8699).

    Article Title: Extracellular matrix proteins modulate lymphatic endothelial cell junction morphology and barrier function
    Article Snippet: .. Primary human dermal lymphatic endothelial cells (LECs) (Promocell, C12217) were cultured on rat tail collagen type I in Endothelial Cell Growth Microvascular Media (EGMV2) (Promocell, C-22121) supplemented with insulin-like growth factors, fibroblast growth factors with fetal calf serum. ..



    Similar Products

    primary human dermal lymphatic endothelial cells lecs  (PromoCell)
    96
    PromoCell primary human dermal lymphatic endothelial cells lecs
    Primary Human Dermal Lymphatic Endothelial Cells Lecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+human+dermal+lymphatic+endothelial+cells+lecs/Human+Dermal+Lymphatic+Endothelial+Cells+(HDLEC)+juvenile+foreskin/bio_rxiv__64898__2026__01__30__702887-112-0-7
    Average 96 stars, based on 1 article reviews
    primary human dermal lymphatic endothelial cells lecs - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    primary human dermal lymphatic endothelial cells lec  (PromoCell)
    96
    PromoCell primary human dermal lymphatic endothelial cells lec
    A-C. HeLa cells expressing SOX18wt, mutants C240X (dominant-negative transactivation deficient) or HMGdel (DNA-binding deficient), or mCherry as a control, and thereafter infected with rKSHV.219 for 72h (KSHV-HeLa). A. IF images of the SOX18wt and mutants expressing cells labeled with anti-SOX18 antibody and a schematic of the constructs. B. Immunoblotting with anti-SOX18 antibody using β-actin as a loading control for normalization. C. RT-qPCR for the indicated viral genes in KSHV-HeLa. D. LECs infected with rKSHV.219 (KLECs) for 72 hours and treated with Sm4 or DMSO control for 24h and relative mRNA measured for indicated viral transcripts. Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons; ns = non-significant. E-F. Uninfected LECs and KLECs 72h p.i. treated with DMSO or Sm4 for another 72h and E) labeled with anti-ARID1A and -BRG1 antibodies, nuclei were counterstained with Hoechst (33342), scale bar is 10µm, and F) immunoblotted for the indicated proteins and quantified as in B.
    Primary Human Dermal Lymphatic Endothelial Cells Lec, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+human+dermal+lymphatic+endothelial+cells+lecs/Human+Dermal+Lymphatic+Endothelial+Cells+(HDLEC)+juvenile+foreskin/bio_rxiv__2025__06__28__662102-246-0-7
    Average 96 stars, based on 1 article reviews
    primary human dermal lymphatic endothelial cells lec - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    primary human dermal lymphatic cells lec  (PromoCell)
    96
    PromoCell primary human dermal lymphatic cells lec
    A-C. HeLa cells expressing SOX18wt, mutants C240X (dominant-negative transactivation deficient) or HMGdel (DNA-binding deficient), or mCherry as a control, and thereafter infected with rKSHV.219 for 72h (KSHV-HeLa). A. IF images of the SOX18wt and mutants expressing cells labeled with anti-SOX18 antibody and a schematic of the constructs. B. Immunoblotting with anti-SOX18 antibody using β-actin as a loading control for normalization. C. RT-qPCR for the indicated viral genes in KSHV-HeLa. D. LECs infected with rKSHV.219 (KLECs) for 72 hours and treated with Sm4 or DMSO control for 24h and relative mRNA measured for indicated viral transcripts. Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons; ns = non-significant. E-F. Uninfected LECs and KLECs 72h p.i. treated with DMSO or Sm4 for another 72h and E) labeled with anti-ARID1A and -BRG1 antibodies, nuclei were counterstained with Hoechst (33342), scale bar is 10µm, and F) immunoblotted for the indicated proteins and quantified as in B.
    Primary Human Dermal Lymphatic Cells Lec, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+human+dermal+lymphatic+endothelial+cells+lecs/Human+Dermal+Lymphatic+Endothelial+Cells+(HDLEC)+juvenile+foreskin/pmc12047821-292-0-7
    Average 96 stars, based on 1 article reviews
    primary human dermal lymphatic cells lec - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    primary dermal lymphatic endothelial cells lecs  (PromoCell)
    96
    PromoCell primary dermal lymphatic endothelial cells lecs
    A-C. HeLa cells expressing SOX18wt, mutants C240X (dominant-negative transactivation deficient) or HMGdel (DNA-binding deficient), or mCherry as a control, and thereafter infected with rKSHV.219 for 72h (KSHV-HeLa). A. IF images of the SOX18wt and mutants expressing cells labeled with anti-SOX18 antibody and a schematic of the constructs. B. Immunoblotting with anti-SOX18 antibody using β-actin as a loading control for normalization. C. RT-qPCR for the indicated viral genes in KSHV-HeLa. D. LECs infected with rKSHV.219 (KLECs) for 72 hours and treated with Sm4 or DMSO control for 24h and relative mRNA measured for indicated viral transcripts. Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons; ns = non-significant. E-F. Uninfected LECs and KLECs 72h p.i. treated with DMSO or Sm4 for another 72h and E) labeled with anti-ARID1A and -BRG1 antibodies, nuclei were counterstained with Hoechst (33342), scale bar is 10µm, and F) immunoblotted for the indicated proteins and quantified as in B.
    Primary Dermal Lymphatic Endothelial Cells Lecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+human+dermal+lymphatic+endothelial+cells+lecs/Human+Dermal+Lymphatic+Endothelial+Cells/pm39471213-228-0-7
    Average 96 stars, based on 1 article reviews
    primary dermal lymphatic endothelial cells lecs - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    primary lymphatic endothelial cell lec culture  (PromoCell)
    96
    PromoCell primary lymphatic endothelial cell lec culture
    A-C. HeLa cells expressing SOX18wt, mutants C240X (dominant-negative transactivation deficient) or HMGdel (DNA-binding deficient), or mCherry as a control, and thereafter infected with rKSHV.219 for 72h (KSHV-HeLa). A. IF images of the SOX18wt and mutants expressing cells labeled with anti-SOX18 antibody and a schematic of the constructs. B. Immunoblotting with anti-SOX18 antibody using β-actin as a loading control for normalization. C. RT-qPCR for the indicated viral genes in KSHV-HeLa. D. LECs infected with rKSHV.219 (KLECs) for 72 hours and treated with Sm4 or DMSO control for 24h and relative mRNA measured for indicated viral transcripts. Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons; ns = non-significant. E-F. Uninfected LECs and KLECs 72h p.i. treated with DMSO or Sm4 for another 72h and E) labeled with anti-ARID1A and -BRG1 antibodies, nuclei were counterstained with Hoechst (33342), scale bar is 10µm, and F) immunoblotted for the indicated proteins and quantified as in B.
    Primary Lymphatic Endothelial Cell Lec Culture, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+human+dermal+lymphatic+endothelial+cells+lecs/HDLEC-c+Human+Dermal+Lymphatic+Endothelial+Cells/pm38877304-293-0-23
    Average 96 stars, based on 1 article reviews
    primary lymphatic endothelial cell lec culture - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    primary human lecs  (PromoCell)
    96
    PromoCell primary human lecs
    A-C. HeLa cells expressing SOX18wt, mutants C240X (dominant-negative transactivation deficient) or HMGdel (DNA-binding deficient), or mCherry as a control, and thereafter infected with rKSHV.219 for 72h (KSHV-HeLa). A. IF images of the SOX18wt and mutants expressing cells labeled with anti-SOX18 antibody and a schematic of the constructs. B. Immunoblotting with anti-SOX18 antibody using β-actin as a loading control for normalization. C. RT-qPCR for the indicated viral genes in KSHV-HeLa. D. LECs infected with rKSHV.219 (KLECs) for 72 hours and treated with Sm4 or DMSO control for 24h and relative mRNA measured for indicated viral transcripts. Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons; ns = non-significant. E-F. Uninfected LECs and KLECs 72h p.i. treated with DMSO or Sm4 for another 72h and E) labeled with anti-ARID1A and -BRG1 antibodies, nuclei were counterstained with Hoechst (33342), scale bar is 10µm, and F) immunoblotted for the indicated proteins and quantified as in B.
    Primary Human Lecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+human+dermal+lymphatic+endothelial+cells+lecs/Human+Dermal+Lymphatic+Endothelial+Cells/pmc10923144-102-2-6
    Average 96 stars, based on 1 article reviews
    primary human lecs - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    A-C. HeLa cells expressing SOX18wt, mutants C240X (dominant-negative transactivation deficient) or HMGdel (DNA-binding deficient), or mCherry as a control, and thereafter infected with rKSHV.219 for 72h (KSHV-HeLa). A. IF images of the SOX18wt and mutants expressing cells labeled with anti-SOX18 antibody and a schematic of the constructs. B. Immunoblotting with anti-SOX18 antibody using β-actin as a loading control for normalization. C. RT-qPCR for the indicated viral genes in KSHV-HeLa. D. LECs infected with rKSHV.219 (KLECs) for 72 hours and treated with Sm4 or DMSO control for 24h and relative mRNA measured for indicated viral transcripts. Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons; ns = non-significant. E-F. Uninfected LECs and KLECs 72h p.i. treated with DMSO or Sm4 for another 72h and E) labeled with anti-ARID1A and -BRG1 antibodies, nuclei were counterstained with Hoechst (33342), scale bar is 10µm, and F) immunoblotted for the indicated proteins and quantified as in B.

    Journal: bioRxiv

    Article Title: Oncogenic virus hijacks SOX18 pioneer function to enhance viral persistence

    doi: 10.1101/2025.06.28.662102

    Figure Lengend Snippet: A-C. HeLa cells expressing SOX18wt, mutants C240X (dominant-negative transactivation deficient) or HMGdel (DNA-binding deficient), or mCherry as a control, and thereafter infected with rKSHV.219 for 72h (KSHV-HeLa). A. IF images of the SOX18wt and mutants expressing cells labeled with anti-SOX18 antibody and a schematic of the constructs. B. Immunoblotting with anti-SOX18 antibody using β-actin as a loading control for normalization. C. RT-qPCR for the indicated viral genes in KSHV-HeLa. D. LECs infected with rKSHV.219 (KLECs) for 72 hours and treated with Sm4 or DMSO control for 24h and relative mRNA measured for indicated viral transcripts. Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons; ns = non-significant. E-F. Uninfected LECs and KLECs 72h p.i. treated with DMSO or Sm4 for another 72h and E) labeled with anti-ARID1A and -BRG1 antibodies, nuclei were counterstained with Hoechst (33342), scale bar is 10µm, and F) immunoblotted for the indicated proteins and quantified as in B.

    Article Snippet: Primary human dermal lymphatic endothelial cells LEC (Promocell; C-12216) were maintained in Microvascular MV-2 (Promocell; C-22121) medium supplemented with 5% fetal bovine serum, basic fibroblast growth factor, insulin-like growth factor 3, epidermal growth factor, gentamicin sulfate/amphotericin, ascorbic acid, and hydrocortisone; VEGF was not added.

    Techniques: Expressing, Dominant Negative Mutation, Binding Assay, Control, Infection, Labeling, Construct, Western Blot, Quantitative RT-PCR

    A-C. A schematic of the inhibitor mode of action is shown in the top panels. CTG viability assay of uninfected LECs (LEC) or LECs infected with rKSHV.219 (KLEC) for 72h and treated with the indicated, increasing concentrations of BRG1 inhibitors A) ACBI1, B) FHT-1015 and C) PFI-3 (n=3), arrows indicate the selected concentration for following inhibitor assays. D. LECs and KLECs were treated with ACBI1, FHT-1015 and PFI-3 and treated with EdU for 4h before subjecting to EdU Click-It, imaged with Opera Phenix 20x and quantified from (n=6 independent replicates, and from each n=100 nuclei). Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons, ns = non-significant. E-F. LECs infected with ΔORF50 and treated with Sm4, FHT-1015, or DMSO for 72h and processed for ATAC-seq. E. Peaks and heatmaps of the top 1000 genomic regions with reduced overall accessibility (dark blue maps) showing shared (dark blue line), unique to Sm4 (turquoise) and unique to FHT-1015 (purple) loss sites. F. Pearson’s analysis of the replicate (n = 3) samples. ns = non-significant.

    Journal: bioRxiv

    Article Title: Oncogenic virus hijacks SOX18 pioneer function to enhance viral persistence

    doi: 10.1101/2025.06.28.662102

    Figure Lengend Snippet: A-C. A schematic of the inhibitor mode of action is shown in the top panels. CTG viability assay of uninfected LECs (LEC) or LECs infected with rKSHV.219 (KLEC) for 72h and treated with the indicated, increasing concentrations of BRG1 inhibitors A) ACBI1, B) FHT-1015 and C) PFI-3 (n=3), arrows indicate the selected concentration for following inhibitor assays. D. LECs and KLECs were treated with ACBI1, FHT-1015 and PFI-3 and treated with EdU for 4h before subjecting to EdU Click-It, imaged with Opera Phenix 20x and quantified from (n=6 independent replicates, and from each n=100 nuclei). Statistical significance was determined by one-way ANOVA with Dunnett correction for multiple comparisons, ns = non-significant. E-F. LECs infected with ΔORF50 and treated with Sm4, FHT-1015, or DMSO for 72h and processed for ATAC-seq. E. Peaks and heatmaps of the top 1000 genomic regions with reduced overall accessibility (dark blue maps) showing shared (dark blue line), unique to Sm4 (turquoise) and unique to FHT-1015 (purple) loss sites. F. Pearson’s analysis of the replicate (n = 3) samples. ns = non-significant.

    Article Snippet: Primary human dermal lymphatic endothelial cells LEC (Promocell; C-12216) were maintained in Microvascular MV-2 (Promocell; C-22121) medium supplemented with 5% fetal bovine serum, basic fibroblast growth factor, insulin-like growth factor 3, epidermal growth factor, gentamicin sulfate/amphotericin, ascorbic acid, and hydrocortisone; VEGF was not added.

    Techniques: Viability Assay, Infection, Concentration Assay